MCA
BSX icon

McGuire Capital Advisors’s Boston Scientific BSX Stock Holding History

McGuire Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.43K Buy
174
+94
+118% +$5.1K ﹤0.01% 499
2026
Q1 		$5.02K Buy
80
+5
+7% +$400 ﹤0.01% 520
2025
Q4 		$7.15K Buy
+75
New +$7.35K ﹤0.01% 468

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

McGuire Capital Advisors's BSX Position: Q2 2026 in Review

McGuire Capital Advisors increased its Boston Scientific (BSX) stake by 118% in Q2 2026, buying an estimated $5.1K and bringing the position to 174 shares worth $7.43K. The position accounts for ﹤0.01% of the portfolio, ranked #499.

McGuire Capital Advisors first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • McGuire Capital Advisors held 174 shares of Boston Scientific worth $7.43K as of Q2 2026.
  • McGuire Capital Advisors bought 94 Boston Scientific shares in Q2 2026, an estimated $5.1K.
  • Boston Scientific made up ﹤0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #499 holding.
  • McGuire Capital Advisors first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.